DCF — MYMICHIGAN MEDICAL CTR - WEST BRAN
Enterprise Value: $-114.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-114.8M
Enterprise Value
$-36.2M
PV of Cash Flows
$-78.6M
PV of Terminal Value
$-126.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $67.0M | $-7.2M | -11.0% | $-10.1M | $-9.2M |
| Year 2 | $69.0M | $-6.8M | -10.0% | $-9.7M | $-8.0M |
| Year 3 | $71.1M | $-6.3M | -9.0% | $-9.3M | $-7.0M |
| Year 4 | $73.2M | $-6.1M | -8.0% | $-9.2M | $-6.3M |
| Year 5 | $75.4M | $-6.1M | -8.0% | $-9.3M | $-5.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-114.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$65.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11308097568182625
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5